Literature DB >> 26135944

Alcohol-induced hypertension: an important healthcare target in Belgium.

F Collart1, P de Timary, G Dom, B D Dor, D Duprez, J-P Lengelé, F Matthys, H Peuskens, J Rehm, P Stärkel.   

Abstract

Excessive alcohol intake is one of the leading causes of premature death in Europe and particularly in Belgium. Belgian people are consuming more alcohol per year than the European average. It is well established that excessive alcohol consumption is a significant predictor of the development of hypertension (HTN). Two million adults in Belgium suffer from HTN and this number will increase to three million by 2025. Less than 50% of Belgian people treated for HTN are well-controlled. Alcohol reduction in patients with HTN can significantly lower systolic and diastolic blood pressure. After reviewing the epidemiology of HTN and alcohol disorders in Belgium, this paper will focus on the rationale for alcohol screening and brief intervention in primary care. It will also describe the barriers to alcohol screening, and what could be the benefits of alcohol screening for our healthcare system. The authors believe that early identification through alcohol screening and brief intervention in general practice can help to improve the management of patients with HTN, to reach the targets of the WHO Global Action Plan, i.e., a 25% relative reduction in the risk of premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases. They are also convinced that this would allow achieving major healthcare savings.

Entities:  

Keywords:  Alcohol screening; Alcohol use disorder; Harmful alcohol use; Hypertension; Primary care

Mesh:

Year:  2015        PMID: 26135944     DOI: 10.1179/2295333715Y.0000000039

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  5 in total

1.  Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.

Authors:  Jürgen Rehm; Peter Anderson; Jose Angel Arbesu Prieto; Iain Armstrong; Henri-Jean Aubin; Michael Bachmann; Nuria Bastida Bastus; Carlos Brotons; Robyn Burton; Manuel Cardoso; Joan Colom; Daniel Duprez; Gerrit Gmel; Antoni Gual; Ludwig Kraus; Reinhold Kreutz; Helena Liira; Jakob Manthey; Lars Møller; Ľubomír Okruhlica; Michael Roerecke; Emanuele Scafato; Bernd Schulte; Lidia Segura-Garcia; Kevin David Shield; Cristina Sierra; Konstantin Vyshinskiy; Marcin Wojnar; José Zarco
Journal:  BMC Med       Date:  2017-09-28       Impact factor: 8.775

2.  The role of alcohol in the management of hypertension in patients in European primary health care practices - a survey in the largest European Union countries.

Authors:  Jürgen Rehm; Jose Angel Arbesu Prieto; Markus Beier; Didier Duhot; Alessandro Rossi; Bernd Schulte; José Zarco; Henri-Jean Aubin; Michael Bachmann; Carsten Grimm; Ludwig Kraus; Jakob Manthey; Emanuele Scafato; Antoni Gual
Journal:  BMC Fam Pract       Date:  2016-09-08       Impact factor: 2.497

3.  Undiagnosed Hyperglycaemia and Hypertension as Indicators of the Various Risk Factors of Future Cardiovascular Disease Among Population of Serbian Students.

Authors:  Andrijana Milošević Georgiev; Dušanka Krajnović; Jelena Kotur-Stevuljević; Svetlana Ignjatović; Valentina Marinković
Journal:  J Med Biochem       Date:  2018-07-01       Impact factor: 3.402

4.  The effect of brief versus individually tailored dietary advice on change in diet, lipids and blood pressure in patients with inflammatory joint disease.

Authors:  Maria Grorud Fagerhøi; Silvia Rollefstad; Sissel Urke Olsen; Anne Grete Semb
Journal:  Food Nutr Res       Date:  2018-09-04       Impact factor: 3.894

5.  Moderation of alcohol consumption as a recommendation in European hypertension management guidelines: a survey on awareness, screening and implementation among European physicians.

Authors:  Laila Zaidi Touis; Juliane Bolbrinker; Thomas Günther Riemer; Reinhold Kreutz
Journal:  BMJ Open       Date:  2018-10-21       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.